Trademarkia Logo

Canada

C$
Trademark Search in Canada
BBI503

View On IC.GC.CA

BBI503
REGISTERED

on 7 Sept 2016

Last Applicant/ Owned by

BOSTON BIOMEDICAL INC.

640 Memorial DriveCambridge, MA 02139

US

Serial Number

1697320 filed on 8th Oct 2014

Registration Number

TMA948614 registered on 7th Sept 2016

Registration expiry Date

7th Sept 2031

Correspondent Address

JENSEN IP

234 - 38 Auriga DriveOttawa,

ONTARIO

CA

K2E8A5

BBI503

Trademark usage description

pharmaceutical preparation, namely, a kinase to treat cancer, diabetes, autoimmune disorders, including rheumatoid arthritis, proliferative disorders, Read More

Classification Information

Class [005]
Pharmaceutical preparation, namely, a kinase to treat cancer, diabetes, autoimmune disorders, including rheumatoid arthritis, proliferative disorders, namely psoriasis, angiogenesis, inflammatory disorders, namely inflammatory bowel diseases, immunological disorders, namely autoimmune diseases, immunologic deficiency syndromes, and aspergillosis cardiovascular disorders, including restenosis, fibrosis, von Heppel-Lindau disease, osteoarthritis, neurodegeneration, infections, namely respiratory infections, topical infections, central nervous system infections, bacterial infections and viral infections

Classification kind code

10

Mark Details

Serial Number

1697320

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 51
on 20th May 2016		Allowance Notice Sent
Submitted for opposition 42
on 3rd Feb 2016		Advertised
Submitted for opposition 26
on 14th Jan 2016		Approved
Submitted for opposition 27
on 27th Nov 2015		Approval Notice Sent
Submitted for opposition 22
on 24th Apr 2015		Search Recorded
Submitted for opposition 20
on 24th Apr 2015		Examiner's First Report
Submitted for opposition 68
on 15th Jan 2015		Rep for Service Name Changed
Submitted for opposition 31
on 14th Oct 2014		Formalized
Submitted for opposition 1
on 9th Oct 2014		Created
Submitted for opposition 30
on 8th Oct 2014		Filed